Bouya Salehoddin, Balouchi Abbas, Rafiemanesh Hosein, Hesaraki Mehran
Internal Medicine and Nephrology, Clinical Immunology Research Center, Ali-Ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran.
Student Research Committee, Nursing and Midwifery School, Iran University of Medical Sciences, Tehran, Iran.
Ther Apher Dial. 2018 Dec;22(6):594-599. doi: 10.1111/1744-9987.12716. Epub 2018 Jul 4.
The aim of this study was to determine the prevalence of CKD in the Iranian general population. In this systematic review and meta-analysis study, international (PubMed, Web of Science, Scopus, and Google scholar) and national databases (SID, Magiran) were searched until December 30, 2017. The quality of the studies was evaluated using the Hoy instrument. Out of 1170 initial studies, 9 studies with a total of 70 605 participants were included in the final stage of this study. Based on the results of the random effect method (95% CI), the overall prevalence of chronic kidney disease in 70 605 people was 15.14% (I = 99.77%). The prevalence of CKD in female patients (18.80%) was 1.7 times higher than in male patients (10.83). The results of the present study indicate a higher than the global average prevalence of CKD in Iran and the need for additional attention of policy makers on better planning for control and implementation of screening programs in high-risk populations, such as patients with hypertension and diabetes.
本研究的目的是确定伊朗普通人群中慢性肾脏病（CKD）的患病率。在这项系统评价和荟萃分析研究中，检索了国际数据库（PubMed、科学网、Scopus和谷歌学术）和国内数据库（SID、Magiran），检索截止至2017年12月30日。使用Hoy工具评估研究质量。在1170项初始研究中，9项研究共70605名参与者被纳入本研究的最后阶段。基于随机效应方法的结果（95%置信区间），70605人中慢性肾脏病的总体患病率为15.14%（I² = 99.77%）。女性患者CKD的患病率（18.80%）比男性患者（10.83%）高1.7倍。本研究结果表明，伊朗CKD的患病率高于全球平均水平，政策制定者需要更多关注，以便更好地规划对高血压和糖尿病等高危人群筛查项目的控制和实施。
